Related Experiment Video
Updated: Oct 30, 2025
11:28
Designing, Packaging, and Delivery of High Titer CRISPR Retro and Lentiviruses via Stereotaxic Injection
Published on: May 23, 2016
17.9K
CRISPR-Associated (CAS) Effectors Delivery via Microfluidic Cell-Deformation Chip.
Noshad Peyravian1,2, Maziar Malekzadeh Kebria1,2, Jafar Kiani3,4
1Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran 1449614535, Iran.
Materials (Basel, Switzerland)
|July 2, 2021
Summary
Microfluidic systems offer advanced solutions for delivering CRISPR gene editing tools, overcoming challenges with traditional methods for enhanced gene therapy applications.
Area of Science:
- Molecular Biology
- Biotechnology
- Bioengineering
Background:
- CRISPR-Cas systems are revolutionizing gene editing for research and therapeutics.
- Efficient and precise delivery of CRISPR components is crucial for genome engineering.
- Conventional delivery methods like viral and chemical vectors face limitations in efficiency and packaging capacity.
Purpose of the Study:
- To review recent advancements in microfluidic systems for CRISPR-Cas delivery.
- To highlight the potential of microfluidics in clinical and therapeutic applications of gene editing.
Main Methods:
- Focus on physical delivery methods, specifically microfluidic systems.
- Discuss the advantages of microfluidics over conventional viral and chemical vectors.
- Analyze recent developments in microfluidic technology for CRISPR delivery.
Main Results:
- Microfluidic systems show promise for efficient in vitro delivery of CRISPR components.
- These systems can overcome limitations associated with conventional delivery tools.
- Advancements in microfluidics offer improved applicability for clinical gene therapy investigations.
Conclusions:
- Microfluidics represent a significant advancement for CRISPR-Cas system delivery.
- This technology holds great potential for overcoming current gene delivery challenges in therapy.
- Further development of microfluidic systems is key for future genome regulation strategies.
